{"transactions":[{"id":1583559,"issuer":{"id":11424,"kind":"organization","name":"Harpoon Therapeutics, Inc.","symbol":"HARP"},"owners":[{"id":93214,"kind":"person","name":"DRACHMAN JONATHAN G","position":1,"cik":"0001588467","reported_name":"DRACHMAN JONATHAN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2024-03-11T17:19:18.000Z","date":"2024-03-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2300,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of January 7, 2024, by and among the Issuer, Merck Sharp & Dohme LLC, a New Jersey limited liability company (\"Parent\"), and Hawaii Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (\"Merger Sub\"), pursuant to which Merger Sub merged with and into the Issuer on March 11, 2024, with the Issuer surviving the merger as a wholly owned subsidiary of Parent (the \"Merger\")."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each outstanding option to purchase shares of Common Stock granted under an Issuer equity plan (each, a \"Stock Option\"), to the extent unvested, became fully vested and exercisable effective immediately prior to, and contingent upon, the Effective Time. Pursuant to the terms of the Merger Agreement, at the Effective Time, (i) each Stock Option that was outstanding and unexercised immediately prior to the Effective Time and that had a per share exercise price that is less than the Common Stock Merger Consideration (each, an \"In the Money Option\")"},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"(Continued from footnote 6) was cancelled in exchange for the right to receive an amount in cash (without interest and subject to any applicable withholding or other taxes) equal to the product of (1) the total number of shares of Common Stock subject to such Stock Option immediately prior to the Effective Time and (2) the excess of the Common Stock Merger Consideration over the per share exercise price payable for such Stock Option immediately prior to the Effective Time and (ii) each Stock Option other than an In the Money Option then outstanding and unexercised was cancelled with no consideration payable in respect thereof."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each outstanding option to purchase shares of Common Stock granted under an Issuer equity plan (each, a \"Stock Option\"), to the extent unvested, became fully vested and exercisable effective immediately prior to, and contingent upon, the Effective Time. Pursuant to the terms of the Merger Agreement, at the Effective Time, (i) each Stock Option that was outstanding and unexercised immediately prior to the Effective Time and that had a per share exercise price that is less than the Common Stock Merger Consideration (each, an \"In the Money Option\")"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"(Continued from footnote 6) was cancelled in exchange for the right to receive an amount in cash (without interest and subject to any applicable withholding or other taxes) equal to the product of (1) the total number of shares of Common Stock subject to such Stock Option immediately prior to the Effective Time and (2) the excess of the Common Stock Merger Consideration over the per share exercise price payable for such Stock Option immediately prior to the Effective Time and (ii) each Stock Option other than an In the Money Option then outstanding and unexercised was cancelled with no consideration payable in respect thereof."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each outstanding option to purchase shares of Common Stock granted under an Issuer equity plan (each, a \"Stock Option\"), to the extent unvested, became fully vested and exercisable effective immediately prior to, and contingent upon, the Effective Time. Pursuant to the terms of the Merger Agreement, at the Effective Time, (i) each Stock Option that was outstanding and unexercised immediately prior to the Effective Time and that had a per share exercise price that is less than the Common Stock Merger Consideration (each, an \"In the Money Option\")"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"(Continued from footnote 6) was cancelled in exchange for the right to receive an amount in cash (without interest and subject to any applicable withholding or other taxes) equal to the product of (1) the total number of shares of Common Stock subject to such Stock Option immediately prior to the Effective Time and (2) the excess of the Common Stock Merger Consideration over the per share exercise price payable for such Stock Option immediately prior to the Effective Time and (ii) each Stock Option other than an In the Money Option then outstanding and unexercised was cancelled with no consideration payable in respect thereof."}],"balance_after":0,"derivative":{"exercise_price":6.657,"underlying":"Common Stock","underlying_shares":2300},"source":{"system":"sec-edgar","filing":"0000950170-24-029434","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1588467/000095017024029434/ownership.xml","form_type":"4"}},{"id":1583558,"issuer":{"id":11424,"kind":"organization","name":"Harpoon Therapeutics, Inc.","symbol":"HARP"},"owners":[{"id":93214,"kind":"person","name":"DRACHMAN JONATHAN G","position":1,"cik":"0001588467","reported_name":"DRACHMAN JONATHAN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2024-03-11T17:19:18.000Z","date":"2024-03-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1016,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of January 7, 2024, by and among the Issuer, Merck Sharp & Dohme LLC, a New Jersey limited liability company (\"Parent\"), and Hawaii Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (\"Merger Sub\"), pursuant to which Merger Sub merged with and into the Issuer on March 11, 2024, with the Issuer surviving the merger as a wholly owned subsidiary of Parent (the \"Merger\")."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each outstanding option to purchase shares of Common Stock granted under an Issuer equity plan (each, a \"Stock Option\"), to the extent unvested, became fully vested and exercisable effective immediately prior to, and contingent upon, the Effective Time. Pursuant to the terms of the Merger Agreement, at the Effective Time, (i) each Stock Option that was outstanding and unexercised immediately prior to the Effective Time and that had a per share exercise price that is less than the Common Stock Merger Consideration (each, an \"In the Money Option\")"},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"(Continued from footnote 6) was cancelled in exchange for the right to receive an amount in cash (without interest and subject to any applicable withholding or other taxes) equal to the product of (1) the total number of shares of Common Stock subject to such Stock Option immediately prior to the Effective Time and (2) the excess of the Common Stock Merger Consideration over the per share exercise price payable for such Stock Option immediately prior to the Effective Time and (ii) each Stock Option other than an In the Money Option then outstanding and unexercised was cancelled with no consideration payable in respect thereof."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each outstanding option to purchase shares of Common Stock granted under an Issuer equity plan (each, a \"Stock Option\"), to the extent unvested, became fully vested and exercisable effective immediately prior to, and contingent upon, the Effective Time. Pursuant to the terms of the Merger Agreement, at the Effective Time, (i) each Stock Option that was outstanding and unexercised immediately prior to the Effective Time and that had a per share exercise price that is less than the Common Stock Merger Consideration (each, an \"In the Money Option\")"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"(Continued from footnote 6) was cancelled in exchange for the right to receive an amount in cash (without interest and subject to any applicable withholding or other taxes) equal to the product of (1) the total number of shares of Common Stock subject to such Stock Option immediately prior to the Effective Time and (2) the excess of the Common Stock Merger Consideration over the per share exercise price payable for such Stock Option immediately prior to the Effective Time and (ii) each Stock Option other than an In the Money Option then outstanding and unexercised was cancelled with no consideration payable in respect thereof."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each outstanding option to purchase shares of Common Stock granted under an Issuer equity plan (each, a \"Stock Option\"), to the extent unvested, became fully vested and exercisable effective immediately prior to, and contingent upon, the Effective Time. Pursuant to the terms of the Merger Agreement, at the Effective Time, (i) each Stock Option that was outstanding and unexercised immediately prior to the Effective Time and that had a per share exercise price that is less than the Common Stock Merger Consideration (each, an \"In the Money Option\")"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"(Continued from footnote 6) was cancelled in exchange for the right to receive an amount in cash (without interest and subject to any applicable withholding or other taxes) equal to the product of (1) the total number of shares of Common Stock subject to such Stock Option immediately prior to the Effective Time and (2) the excess of the Common Stock Merger Consideration over the per share exercise price payable for such Stock Option immediately prior to the Effective Time and (ii) each Stock Option other than an In the Money Option then outstanding and unexercised was cancelled with no consideration payable in respect thereof."}],"balance_after":0,"derivative":{"exercise_price":20.1,"underlying":"Common Stock","underlying_shares":1016},"source":{"system":"sec-edgar","filing":"0000950170-24-029434","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1588467/000095017024029434/ownership.xml","form_type":"4"}},{"id":1583557,"issuer":{"id":11424,"kind":"organization","name":"Harpoon Therapeutics, Inc.","symbol":"HARP"},"owners":[{"id":93214,"kind":"person","name":"DRACHMAN JONATHAN G","position":1,"cik":"0001588467","reported_name":"DRACHMAN JONATHAN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2024-03-11T17:19:18.000Z","date":"2024-03-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":5531,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of January 7, 2024, by and among the Issuer, Merck Sharp & Dohme LLC, a New Jersey limited liability company (\"Parent\"), and Hawaii Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (\"Merger Sub\"), pursuant to which Merger Sub merged with and into the Issuer on March 11, 2024, with the Issuer surviving the merger as a wholly owned subsidiary of Parent (the \"Merger\")."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each outstanding option to purchase shares of Common Stock granted under an Issuer equity plan (each, a \"Stock Option\"), to the extent unvested, became fully vested and exercisable effective immediately prior to, and contingent upon, the Effective Time. Pursuant to the terms of the Merger Agreement, at the Effective Time, (i) each Stock Option that was outstanding and unexercised immediately prior to the Effective Time and that had a per share exercise price that is less than the Common Stock Merger Consideration (each, an \"In the Money Option\")"},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"(Continued from footnote 6) was cancelled in exchange for the right to receive an amount in cash (without interest and subject to any applicable withholding or other taxes) equal to the product of (1) the total number of shares of Common Stock subject to such Stock Option immediately prior to the Effective Time and (2) the excess of the Common Stock Merger Consideration over the per share exercise price payable for such Stock Option immediately prior to the Effective Time and (ii) each Stock Option other than an In the Money Option then outstanding and unexercised was cancelled with no consideration payable in respect thereof."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each outstanding option to purchase shares of Common Stock granted under an Issuer equity plan (each, a \"Stock Option\"), to the extent unvested, became fully vested and exercisable effective immediately prior to, and contingent upon, the Effective Time. Pursuant to the terms of the Merger Agreement, at the Effective Time, (i) each Stock Option that was outstanding and unexercised immediately prior to the Effective Time and that had a per share exercise price that is less than the Common Stock Merger Consideration (each, an \"In the Money Option\")"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"(Continued from footnote 6) was cancelled in exchange for the right to receive an amount in cash (without interest and subject to any applicable withholding or other taxes) equal to the product of (1) the total number of shares of Common Stock subject to such Stock Option immediately prior to the Effective Time and (2) the excess of the Common Stock Merger Consideration over the per share exercise price payable for such Stock Option immediately prior to the Effective Time and (ii) each Stock Option other than an In the Money Option then outstanding and unexercised was cancelled with no consideration payable in respect thereof."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each outstanding option to purchase shares of Common Stock granted under an Issuer equity plan (each, a \"Stock Option\"), to the extent unvested, became fully vested and exercisable effective immediately prior to, and contingent upon, the Effective Time. Pursuant to the terms of the Merger Agreement, at the Effective Time, (i) each Stock Option that was outstanding and unexercised immediately prior to the Effective Time and that had a per share exercise price that is less than the Common Stock Merger Consideration (each, an \"In the Money Option\")"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"(Continued from footnote 6) was cancelled in exchange for the right to receive an amount in cash (without interest and subject to any applicable withholding or other taxes) equal to the product of (1) the total number of shares of Common Stock subject to such Stock Option immediately prior to the Effective Time and (2) the excess of the Common Stock Merger Consideration over the per share exercise price payable for such Stock Option immediately prior to the Effective Time and (ii) each Stock Option other than an In the Money Option then outstanding and unexercised was cancelled with no consideration payable in respect thereof."}],"balance_after":0,"derivative":{"exercise_price":17.703,"underlying":"Common Stock","underlying_shares":5531},"source":{"system":"sec-edgar","filing":"0000950170-24-029434","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1588467/000095017024029434/ownership.xml","form_type":"4"}},{"id":1583556,"issuer":{"id":11424,"kind":"organization","name":"Harpoon Therapeutics, Inc.","symbol":"HARP"},"owners":[{"id":93214,"kind":"person","name":"DRACHMAN JONATHAN G","position":1,"cik":"0001588467","reported_name":"DRACHMAN JONATHAN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-03-11T17:19:18.000Z","date":"2024-03-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":5415,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of January 7, 2024, by and among the Issuer, Merck Sharp & Dohme LLC, a New Jersey limited liability company (\"Parent\"), and Hawaii Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (\"Merger Sub\"), pursuant to which Merger Sub merged with and into the Issuer on March 11, 2024, with the Issuer surviving the merger as a wholly owned subsidiary of Parent (the \"Merger\")."},{"field":"shares","element":"transactionShares","label":"F3","text":"Includes 5,415 RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the terms of the Merger Agreement, at the effective time of the Merger (the \"Effective Time\"), each outstanding RSU was cancelled and automatically converted into the right to receive an amount in cash (without interest and subject to any applicable withholding or other taxes) equal to the product of (i) the Common Stock Merger Consideration (as defined below) payable with respect to such RSU multiplied by (ii) the total number of shares of Common Stock subject to such RSU immediately prior to the Effective Time, with the number of shares of Company Common Stock subject to any such Company RSU that vests based on the achievement of performance goals determined in accordance with the applicable award agreement."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each outstanding share of Common Stock was cancelled and automatically converted into the right to receive $23.00 in cash, without interest (the \"Common Stock Merger Consideration\")."},{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F2","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of January 7, 2024, by and among the Issuer, Merck Sharp & Dohme LLC, a New Jersey limited liability company (\"Parent\"), and Hawaii Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (\"Merger Sub\"), pursuant to which Merger Sub merged with and into the Issuer on March 11, 2024, with the Issuer surviving the merger as a wholly owned subsidiary of Parent (the \"Merger\")."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950170-24-029434","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1588467/000095017024029434/ownership.xml","form_type":"4"}},{"id":1583555,"issuer":{"id":11424,"kind":"organization","name":"Harpoon Therapeutics, Inc.","symbol":"HARP"},"owners":[{"id":93214,"kind":"person","name":"DRACHMAN JONATHAN G","position":1,"cik":"0001588467","reported_name":"DRACHMAN JONATHAN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-03-11T17:19:18.000Z","date":"2024-03-08","kind":"grant","planned":false,"acquired":true,"shares":415,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of the Issuer's common stock, par value $0.0001 per share (\"Common Stock\") issuable upon the settlement of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Common Stock. The fully vested RSUs were granted to the Reporting Person pursuant to the Issuer's Non-Employee Director Compensation Policy in lieu of prorated retainer fees totaling $9,558 for the first quarter of 2024."}],"balance_after":5415,"source":{"system":"sec-edgar","filing":"0000950170-24-029434","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1588467/000095017024029434/ownership.xml","form_type":"4"}},{"id":1728324,"issuer":{"id":11424,"kind":"organization","name":"Harpoon Therapeutics, Inc.","symbol":"HARP"},"owners":[{"id":93214,"kind":"person","name":"DRACHMAN JONATHAN G","position":1,"cik":"0001588467","reported_name":"DRACHMAN JONATHAN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-11-28T16:25:02.000Z","date":"2023-11-27","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock issuable upon the settlement of restricted stock units (\"RSUs\"). 25% of the RSUs will vest on each May 27th and November 27th of 2024 and 2025, subject to acceleration and vesting in full upon a Change in Control (as defined in the Issuer's 2019 Equity Incentive Plan) of the Issuer, and subject to the continuing employment of the Reporting Person on each vesting date."}],"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001209191-23-056795","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1588467/000120919123056795/doc4.xml","form_type":"4"}},{"id":1844881,"issuer":{"id":11424,"kind":"organization","name":"Harpoon Therapeutics, Inc.","symbol":"HARP"},"owners":[{"id":93214,"kind":"person","name":"DRACHMAN JONATHAN G","position":1,"cik":"0001588467","reported_name":"DRACHMAN JONATHAN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2023-06-23T16:32:21.000Z","date":"2023-06-22","kind":"grant","planned":false,"acquired":true,"shares":23000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option will fully vest and become exercisable on June 21, 2024, subject to the continuous service of the Reporting Person with the Issuer on such date."}],"balance_after":23000,"derivative":{"exercise_price":0.6657,"expiration_date":"2033-06-21","underlying":"Common Stock","underlying_shares":23000},"source":{"system":"sec-edgar","filing":"0001209191-23-039407","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1588467/000120919123039407/doc4.xml","form_type":"4"}},{"id":2194384,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":93214,"kind":"person","name":"DRACHMAN JONATHAN G","position":1,"cik":"0001588467","reported_name":"DRACHMAN JONATHAN G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-08-04T20:38:51.000Z","date":"2022-08-02","kind":"grant","acquired":true,"shares":350000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 1/4 of the total shares on August 2, 2023, and then 1/48 of the total shares will vest monthly thereafter, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":350000,"derivative":{"exercise_price":0.99,"expiration_date":"2032-08-01","underlying":"Common Stock","underlying_shares":350000},"source":{"system":"sec-edgar","filing":"0001209191-22-044432","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1404644/000120919122044432/doc4.xml","form_type":"4"}},{"id":2221802,"issuer":{"id":11424,"kind":"organization","name":"Harpoon Therapeutics, Inc.","symbol":"HARP"},"owners":[{"id":93214,"kind":"person","name":"DRACHMAN JONATHAN G","position":1,"cik":"0001588467","reported_name":"DRACHMAN JONATHAN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2022-06-24T18:45:22.000Z","date":"2022-06-22","kind":"grant","acquired":true,"shares":10167,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option will fully vest and become exercisable on June 21, 2023, subject to the continuous service of the Reporting Person with the Issuer on such date."}],"balance_after":10167,"derivative":{"exercise_price":2.01,"expiration_date":"2032-06-21","underlying":"Common Stock","underlying_shares":10167},"source":{"system":"sec-edgar","filing":"0001209191-22-039325","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1588467/000120919122039325/doc4.xml","form_type":"4"}},{"id":2397655,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":93214,"kind":"person","name":"DRACHMAN JONATHAN G","position":1,"cik":"0001588467","reported_name":"DRACHMAN JONATHAN G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-02-15T00:54:34.000Z","date":"2021-10-26","kind":"gift","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held by the JGD Family Trust 2020."}],"balance_after":100000,"source":{"system":"sec-edgar","filing":"0001209191-22-009562","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1404644/000120919122009562/doc5.xml","form_type":"5"}},{"id":2397654,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":93214,"kind":"person","name":"DRACHMAN JONATHAN G","position":1,"cik":"0001588467","reported_name":"DRACHMAN JONATHAN G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-02-15T00:54:34.000Z","date":"2021-10-26","kind":"gift","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are held by the PLD Family Trust 2020."}],"balance_after":100000,"source":{"system":"sec-edgar","filing":"0001209191-22-009562","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1404644/000120919122009562/doc5.xml","form_type":"5"}},{"id":2397653,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":93214,"kind":"person","name":"DRACHMAN JONATHAN G","position":1,"cik":"0001588467","reported_name":"DRACHMAN JONATHAN G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-02-15T00:54:34.000Z","date":"2021-10-26","kind":"gift","acquired":false,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":2198686,"source":{"system":"sec-edgar","filing":"0001209191-22-009562","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1404644/000120919122009562/doc5.xml","form_type":"5"}},{"id":2397652,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":93214,"kind":"person","name":"DRACHMAN JONATHAN G","position":1,"cik":"0001588467","reported_name":"DRACHMAN JONATHAN G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-02-15T00:54:34.000Z","date":"2021-10-26","kind":"gift","acquired":false,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":2198686,"source":{"system":"sec-edgar","filing":"0001209191-22-009562","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1404644/000120919122009562/doc5.xml","form_type":"5"}},{"id":2517776,"issuer":{"id":113073,"kind":"organization","name":"Calithera Biosciences, Inc.","symbol":"CALA"},"owners":[{"id":93214,"kind":"person","name":"DRACHMAN JONATHAN G","position":1,"cik":"0001588467","reported_name":"DRACHMAN JONATHAN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-10T19:31:30.000Z","date":"2021-11-10","kind":"purchase","acquired":true,"shares":200000,"price":0.8595,"value":171900.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.8502 to $0.868, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."}],"balance_after":200000,"source":{"system":"sec-edgar","filing":"0000899243-21-044150","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496671/000089924321044150/doc4.xml","form_type":"4"}},{"id":2589436,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":93214,"kind":"person","name":"DRACHMAN JONATHAN G","position":1,"cik":"0001588467","reported_name":"DRACHMAN JONATHAN G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-08-26T23:08:27.000Z","date":"2021-08-25","kind":"purchase","acquired":true,"shares":25000,"price":6.449,"value":161225.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average purchase price. The lowest price at which shares were purchased was $6.09 and the highest price at which shares were purchased was $6.60."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"These securities are held by a spousal limited access trust of which the Reporting Person's spouse is the primary beneficiary."}],"balance_after":25000,"source":{"system":"sec-edgar","filing":"0001209191-21-053544","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1404644/000120919121053544/doc4.xml","form_type":"4"}},{"id":2589435,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":93214,"kind":"person","name":"DRACHMAN JONATHAN G","position":1,"cik":"0001588467","reported_name":"DRACHMAN JONATHAN G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-08-26T23:08:27.000Z","date":"2021-08-25","kind":"purchase","acquired":true,"shares":25000,"price":6.449,"value":161225.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average purchase price. The lowest price at which shares were purchased was $6.09 and the highest price at which shares were purchased was $6.60."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are held by a spousal limited access trust of which the Reporting Person is the primary beneficiary."}],"balance_after":25000,"source":{"system":"sec-edgar","filing":"0001209191-21-053544","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1404644/000120919121053544/doc4.xml","form_type":"4"}},{"id":2589434,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":93214,"kind":"person","name":"DRACHMAN JONATHAN G","position":1,"cik":"0001588467","reported_name":"DRACHMAN JONATHAN G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-08-26T23:08:27.000Z","date":"2021-08-24","kind":"purchase","acquired":true,"shares":100000,"price":6.111,"value":611100.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average purchase price. The lowest price at which shares were purchased was $6.1099 and the highest price at which shares were purchased was $6.1482. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares purchased at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4."}],"balance_after":2348686,"source":{"system":"sec-edgar","filing":"0001209191-21-053544","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1404644/000120919121053544/doc4.xml","form_type":"4"}},{"id":2612880,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":93214,"kind":"person","name":"DRACHMAN JONATHAN G","position":1,"cik":"0001588467","reported_name":"DRACHMAN JONATHAN G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-08-05T20:12:04.000Z","date":"2021-08-03","kind":"grant","acquired":true,"shares":400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 1/4 of the total shares on August 3, 2022, and then 1/48 of the total shares will vest monthly thereafter, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":400000,"derivative":{"exercise_price":6.8,"expiration_date":"2031-08-03","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001209191-21-049919","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1404644/000120919121049919/doc4.xml","form_type":"4"}},{"id":2670140,"issuer":{"id":113073,"kind":"organization","name":"Calithera Biosciences, Inc.","symbol":"CALA"},"owners":[{"id":93214,"kind":"person","name":"DRACHMAN JONATHAN G","position":1,"cik":"0001588467","reported_name":"DRACHMAN JONATHAN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-14T16:05:34.000Z","date":"2021-06-11","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/12 of the Option vests in each monthly installment as measured from June 11, 2021, until the earlier of the Option's full vesting or the reporting person ceasing to provide continuous service to the issuer.  In addition, in the event of a Change in Control or a Corporate Transaction (each as defined in the plan pursuant to which the Option was granted), any unvested portion of the Option will fully vest and become exercisable as of immediately prior to the effective time of such Change in Control or Corporate Transaction, subject to the reporting person's continuous service on the effective date of such transaction."}],"balance_after":20000,"derivative":{"exercise_price":2.28,"expiration_date":"2031-06-10","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000899243-21-023541","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496671/000089924321023541/doc4.xml","form_type":"4"}},{"id":2679147,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":93214,"kind":"person","name":"DRACHMAN JONATHAN G","position":1,"cik":"0001588467","reported_name":"DRACHMAN JONATHAN G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-06-07T21:06:19.000Z","date":"2021-06-04","kind":"purchase","acquired":true,"shares":10000,"price":9.6082,"value":96082.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average purchase price. The lowest price at which shares were purchased was $9.56 and the highest price at which shares were purchased was $9.62."}],"balance_after":2248686,"source":{"system":"sec-edgar","filing":"0001209191-21-038690","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1404644/000120919121038690/doc4.xml","form_type":"4"}},{"id":2679146,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":93214,"kind":"person","name":"DRACHMAN JONATHAN G","position":1,"cik":"0001588467","reported_name":"DRACHMAN JONATHAN G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-06-07T21:06:19.000Z","date":"2021-06-03","kind":"purchase","acquired":true,"shares":40000,"price":9.4818,"value":379272.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average purchase price. The lowest price at which shares were purchased was $9.38 and the highest price at which shares were purchased was $9.51. The reporting person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares purchased at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4."}],"balance_after":2238686,"source":{"system":"sec-edgar","filing":"0001209191-21-038690","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1404644/000120919121038690/doc4.xml","form_type":"4"}},{"id":2711895,"issuer":{"id":11424,"kind":"organization","name":"Harpoon Therapeutics, Inc.","symbol":"HARP"},"owners":[{"id":93214,"kind":"person","name":"DRACHMAN JONATHAN G","position":1,"cik":"0001588467","reported_name":"DRACHMAN JONATHAN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2021-05-14T19:59:58.000Z","date":"2021-05-04","kind":"grant","acquired":true,"shares":10167,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"This option was erroneously reported with a price of $22.50 on the original Form 4 filed on May 7, 2021 due to an administrative error."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option will fully vest and become exercisable on May 3, 2022, subject to the continuous service of the Reporting Person with the Issuer on such date. The original Form 4 filed on May 7, 2021 erroneously reported this vesting date as May 4, 2022."}],"balance_after":10167,"derivative":{"exercise_price":23.2,"expiration_date":"2031-05-03","underlying":"Common Stock","underlying_shares":10167},"source":{"system":"sec-edgar","filing":"0001209191-21-032952","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1588467/000120919121032952/doc4a.xml","form_type":"4/A","original_submission_date":"2021-05-07"}},{"id":2722424,"issuer":{"id":11424,"kind":"organization","name":"Harpoon Therapeutics, Inc.","symbol":"HARP"},"owners":[{"id":93214,"kind":"person","name":"DRACHMAN JONATHAN G","position":1,"cik":"0001588467","reported_name":"DRACHMAN JONATHAN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2021-05-07T21:53:15.000Z","date":"2021-05-04","kind":"grant","acquired":true,"shares":10167,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option will fully vest and become exercisable on May 4, 2022, subject to the continuous service of the Reporting Person with the Issuer on such date."}],"balance_after":10167,"derivative":{"exercise_price":22.5,"expiration_date":"2031-05-03","underlying":"Common Stock","underlying_shares":10167},"source":{"system":"sec-edgar","filing":"0001209191-21-031104","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1588467/000120919121031104/doc4.xml","form_type":"4"}},{"id":3060059,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":93214,"kind":"person","name":"DRACHMAN JONATHAN G","position":1,"cik":"0001588467","reported_name":"DRACHMAN JONATHAN G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-08-12T20:08:11.000Z","date":"2020-08-10","kind":"grant","acquired":true,"shares":420000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 1/4 of the total shares on August 10, 2021, and then 1/48 of the total shares will vest monthly thereafter, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":420000,"derivative":{"exercise_price":12,"expiration_date":"2030-08-10","underlying":"Common Stock","underlying_shares":420000},"source":{"system":"sec-edgar","filing":"0001209191-20-046339","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1404644/000120919120046339/doc4.xml","form_type":"4"}},{"id":3113372,"issuer":{"id":113073,"kind":"organization","name":"Calithera Biosciences, Inc.","symbol":"CALA"},"owners":[{"id":93214,"kind":"person","name":"DRACHMAN JONATHAN G","position":1,"cik":"0001588467","reported_name":"DRACHMAN JONATHAN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-11T16:01:02.000Z","date":"2020-06-09","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/12 of the Option vests in each monthly installment as measured from June 9, 2020, until the earlier of the Option's full vesting or the reporting person ceasing to provide continuous service to the issuer.  In addition, in the event of a Change in Control or a Corporate Transaction (each as defined in the plan pursuant to which the Option was granted), any unvested portion of the Option will fully vest and become exercisable as of immediately prior to the effective time of such Change in Control or Corporate Transaction, subject to the reporting person's continuous service on the effective date of such transaction."}],"balance_after":20000,"derivative":{"exercise_price":5.25,"expiration_date":"2030-06-08","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000899243-20-016149","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496671/000089924320016149/doc4.xml","form_type":"4"}},{"id":3128713,"issuer":{"id":11424,"kind":"organization","name":"Harpoon Therapeutics, Inc.","symbol":"HARP"},"owners":[{"id":93214,"kind":"person","name":"DRACHMAN JONATHAN G","position":1,"cik":"0001588467","reported_name":"DRACHMAN JONATHAN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2020-06-01T21:42:54.000Z","date":"2020-05-28","kind":"grant","acquired":true,"shares":2880,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable as to 25% of the shares subject to the option on the last day of each calendar quarter following the grant date of May 28, 2020 (on June 30, 2020, September 30, 2020, December 31, 2020, and March 31, 2021), subject to the continuous service of the Reporting Person on each vesting date."}],"balance_after":2880,"derivative":{"exercise_price":20.59,"expiration_date":"2030-05-27","underlying":"Common Stock","underlying_shares":2880},"source":{"system":"sec-edgar","filing":"0001209191-20-033320","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1588467/000120919120033320/doc4.xml","form_type":"4"}},{"id":3128712,"issuer":{"id":11424,"kind":"organization","name":"Harpoon Therapeutics, Inc.","symbol":"HARP"},"owners":[{"id":93214,"kind":"person","name":"DRACHMAN JONATHAN G","position":1,"cik":"0001588467","reported_name":"DRACHMAN JONATHAN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2020-06-01T21:42:54.000Z","date":"2020-05-28","kind":"grant","acquired":true,"shares":10167,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option will fully vest and become exercisable on May 28, 2021, subject to the continuous service of the Reporting Person with the Issuer on such date."}],"balance_after":10167,"derivative":{"exercise_price":20.59,"expiration_date":"2030-05-27","underlying":"Common Stock","underlying_shares":10167},"source":{"system":"sec-edgar","filing":"0001209191-20-033320","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1588467/000120919120033320/doc4.xml","form_type":"4"}},{"id":3333796,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":93214,"kind":"person","name":"DRACHMAN JONATHAN G","position":1,"cik":"0001588467","reported_name":"DRACHMAN JONATHAN G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-12-20T23:53:06.000Z","date":"2019-12-20","kind":"purchase","acquired":true,"shares":119047,"price":8.4,"value":999994.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares purchased in an underwritten public offering of the Issuer's Common Stock."}],"balance_after":2198686,"source":{"system":"sec-edgar","filing":"0000899243-19-029824","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1404644/000089924319029824/doc4.xml","form_type":"4"}},{"id":3333795,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":93214,"kind":"person","name":"DRACHMAN JONATHAN G","position":1,"cik":"0001588467","reported_name":"DRACHMAN JONATHAN G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-12-20T23:53:06.000Z","date":"2019-11-12","kind":"exercise","acquired":true,"shares":1261600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Convertible Preferred Stock converted into 100 shares of the Issuer's Common Stock upon the approval of the Issuer's stockholders on November 12, 2019."}],"balance_after":2079639,"source":{"system":"sec-edgar","filing":"0000899243-19-029824","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1404644/000089924319029824/doc4.xml","form_type":"4"}},{"id":3333794,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":93214,"kind":"person","name":"DRACHMAN JONATHAN G","position":1,"cik":"0001588467","reported_name":"DRACHMAN JONATHAN G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Series A Preferred Stock","published_at":"2019-12-20T23:53:06.000Z","date":"2019-11-12","kind":"exercise","acquired":false,"shares":12616,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Convertible Preferred Stock converted into 100 shares of the Issuer's Common Stock upon the approval of the Issuer's stockholders on November 12, 2019."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-19-029824","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1404644/000089924319029824/doc4.xml","form_type":"4"}},{"id":3415010,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":93214,"kind":"person","name":"DRACHMAN JONATHAN G","position":1,"cik":"0001588467","reported_name":"DRACHMAN JONATHAN G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Series A Preferred Stock","published_at":"2019-09-13T23:18:17.000Z","date":"2019-08-08","kind":"grant","acquired":true,"shares":12616,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This amended Form 4 reflects a correction to the number of shares of Common Stock and Series A Preferred Stock issued to the Reporting Person in connection with the merger of Neoleukin Therapeutics, Inc. (\"Neoleukin\") into Apollo Sub, Inc. (the \"Merger\"), as reported on Form 4 filed on August 12, 2019, and in the Reporting Person's total direct holdings as reported on Form 4 filed on September 11, 2019."},{"field":"security","element":"securityTitle","label":"F3","text":"Each share of Series A Convertible Preferred Stock will become convertible into 100 shares of the Issuer's Common Stock, subject to and contingent upon the approval of the Issuer's stockholders in accordance with the Nasdaq Stock Market Rules.  Under the terms of the Agreement and Plan of Merger (the \"Merger Agreement\") dated August 5, 2019, among Neoleukin, Aquinox Pharmaceuticals, Inc. (the \"Issuer\") and Apollo Sub, Inc., the Issuer has agreed to use commercially reasonable efforts to call and hold a meeting of the Issuer's stockholders to obtain the requisite approval for the conversion of the Series A Convertible Preferred Stock into shares of Common Stock, for purposes of the Nasdaq Stock Market Rules, as soon as practicable and in any event no later than 100 days after the date of the Merger Agreement"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In connection with the Merger, 1,613,614 shares of Common Stock of Neoleukin held by the Reporting Person, including 663,614 shares of Common Stock of Neoleukin issued upon conversion of convertible notes held by the Reporting Person immediately prior to the Merger, were exchanged for 568,039 shares of Common Stock and 12,616 shares of Series A Convertible Preferred Stock."}],"balance_after":12616,"source":{"system":"sec-edgar","filing":"0000899243-19-023581","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1404644/000089924319023581/doc4a.xml","form_type":"4/A","original_submission_date":"2019-08-12"}},{"id":3415009,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":93214,"kind":"person","name":"DRACHMAN JONATHAN G","position":1,"cik":"0001588467","reported_name":"DRACHMAN JONATHAN G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2019-09-13T23:18:17.000Z","date":"2019-08-08","kind":"grant","acquired":true,"shares":568039,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This amended Form 4 reflects a correction to the number of shares of Common Stock and Series A Preferred Stock issued to the Reporting Person in connection with the merger of Neoleukin Therapeutics, Inc. (\"Neoleukin\") into Apollo Sub, Inc. (the \"Merger\"), as reported on Form 4 filed on August 12, 2019, and in the Reporting Person's total direct holdings as reported on Form 4 filed on September 11, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In connection with the Merger, 1,613,614 shares of Common Stock of Neoleukin held by the Reporting Person, including 663,614 shares of Common Stock of Neoleukin issued upon conversion of convertible notes held by the Reporting Person immediately prior to the Merger, were exchanged for 568,039 shares of Common Stock and 12,616 shares of Series A Convertible Preferred Stock."}],"balance_after":568039,"source":{"system":"sec-edgar","filing":"0000899243-19-023581","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1404644/000089924319023581/doc4a.xml","form_type":"4/A","original_submission_date":"2019-08-12"}},{"id":3417524,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":93214,"kind":"person","name":"DRACHMAN JONATHAN G","position":1,"cik":"0001588467","reported_name":"DRACHMAN JONATHAN G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2019-09-11T21:39:06.000Z","date":"2019-09-11","kind":"purchase","acquired":true,"shares":136436,"price":3.2975,"value":449897.71,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average purchase price. The lowest price at which shares were purchased was $3.06 and the highest price at which shares were purchased was $3.50."}],"balance_after":584428,"source":{"system":"sec-edgar","filing":"0000899243-19-023329","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1404644/000089924319023329/doc4.xml","form_type":"4"}},{"id":3417523,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":93214,"kind":"person","name":"DRACHMAN JONATHAN G","position":1,"cik":"0001588467","reported_name":"DRACHMAN JONATHAN G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2019-09-11T21:39:06.000Z","date":"2019-09-10","kind":"purchase","acquired":true,"shares":36742,"price":3.0834,"value":113290.2828,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average purchase price. The lowest price at which shares were purchased was $3.00 and the highest price at which shares were purchased was $3.10."}],"balance_after":447992,"source":{"system":"sec-edgar","filing":"0000899243-19-023329","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1404644/000089924319023329/doc4.xml","form_type":"4"}},{"id":3417522,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":93214,"kind":"person","name":"DRACHMAN JONATHAN G","position":1,"cik":"0001588467","reported_name":"DRACHMAN JONATHAN G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2019-09-11T21:39:06.000Z","date":"2019-09-09","kind":"purchase","acquired":true,"shares":76822,"price":2.845,"value":218558.59,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average purchase price. The lowest price at which shares were purchased was $2.82 and the highest price at which shares were purchased was $2.85. The reporting person undertakes to provide upon request to the staff of the Securities Exchange Commission, the issuer or its stockholders, full information regarding the total number of shares purchased at each separate price within the ranges set forth in footnotes (1), (2) and (3) to this Form 4."}],"balance_after":411250,"source":{"system":"sec-edgar","filing":"0000899243-19-023329","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1404644/000089924319023329/doc4.xml","form_type":"4"}},{"id":3423156,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":93214,"kind":"person","name":"DRACHMAN JONATHAN G","position":1,"cik":"0001588467","reported_name":"DRACHMAN JONATHAN G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-09-04T20:48:00.000Z","date":"2019-08-31","kind":"grant","acquired":true,"shares":1650000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options will vest as to 25% of the total shares on August 31, 2020, and then 2.0833% of the total shares will vest monthly thereafter, such that the option is fully vested on August 31, 2023, subject to the Reporting Person's provision of service to the issuer on each vesting date."}],"balance_after":1650000,"derivative":{"exercise_price":2.8,"expiration_date":"2029-08-31","underlying":"Common Stock","underlying_shares":1650000},"source":{"system":"sec-edgar","filing":"0000899243-19-022733","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1404644/000089924319022733/doc4.xml","form_type":"4"}},{"id":3440961,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":93214,"kind":"person","name":"DRACHMAN JONATHAN G","position":1,"cik":"0001588467","reported_name":"DRACHMAN JONATHAN G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Series A Preferred Stock","published_at":"2019-08-12T21:54:50.000Z","date":"2019-08-08","kind":"grant","acquired":true,"shares":7428,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Each share of Series A Convertible Preferred Stock will become convertible into 100 shares of the Issuer's Common Stock, subject to and contingent upon the approval of the Issuer's stockholders in accordance with the Nasdaq Stock Market Rules. Under the terms of the Agreement and Plan of Merger (the \"Merger Agreement\") dated August 5, 2019, among Neoleukin, Aquinox Pharmaceuticals, Inc. (the \"Issuer\") and Apollo Sub, Inc., the Issuer has agreed to use commercially reasonable efforts to call and hold a meeting of the Issuer's stockholders to obtain the requisite approval for the conversion of the Series A Convertible Preferred Stock into shares of Common Stock, for purposes of the Nasdaq Stock Market Rules, as soon as practicable and in any event no later than 100 days after the date of the Merger Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In connection with the merger of Neoleukin Therapeutics, Inc. (\"Neoleukin\") into Apollo Sub, Inc. (the \"Merger\"), 950,000 shares of Common Stock of Neoleukin held by the Reporting Person were exchanged for 334,428 shares of Common Stock and 7,428 shares of Series A Convertible Preferred Stock."}],"balance_after":7428,"source":{"system":"sec-edgar","filing":"0001213900-19-015390","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1404644/000121390019015390/ownership.xml","form_type":"4"}},{"id":3440960,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":93214,"kind":"person","name":"DRACHMAN JONATHAN G","position":1,"cik":"0001588467","reported_name":"DRACHMAN JONATHAN G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-08-12T21:54:50.000Z","date":"2019-08-08","kind":"grant","acquired":true,"shares":334428,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In connection with the merger of Neoleukin Therapeutics, Inc. (\"Neoleukin\") into Apollo Sub, Inc. (the \"Merger\"), 950,000 shares of Common Stock of Neoleukin held by the Reporting Person were exchanged for 334,428 shares of Common Stock and 7,428 shares of Series A Convertible Preferred Stock."}],"balance_after":334428,"source":{"system":"sec-edgar","filing":"0001213900-19-015390","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1404644/000121390019015390/ownership.xml","form_type":"4"}},{"id":3499974,"issuer":{"id":11424,"kind":"organization","name":"Harpoon Therapeutics, Inc.","symbol":"HARP"},"owners":[{"id":93214,"kind":"person","name":"DRACHMAN JONATHAN G","position":1,"cik":"0001588467","reported_name":"DRACHMAN JONATHAN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2019-06-05T17:20:01.000Z","date":"2019-06-03","kind":"grant","acquired":true,"shares":10167,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option will fully vest and become exercisable on June 3, 2020, subject to the continuous service of the Reporting Person with the Issuer on such date."}],"balance_after":10167,"derivative":{"exercise_price":11.84,"expiration_date":"2029-06-02","underlying":"Common Stock","underlying_shares":10167},"source":{"system":"sec-edgar","filing":"0001209191-19-034841","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1588467/000120919119034841/doc4.xml","form_type":"4"}},{"id":3504706,"issuer":{"id":113073,"kind":"organization","name":"Calithera Biosciences, Inc.","symbol":"CALA"},"owners":[{"id":93214,"kind":"person","name":"DRACHMAN JONATHAN G","position":1,"cik":"0001588467","reported_name":"DRACHMAN JONATHAN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-03T16:06:14.000Z","date":"2019-05-30","kind":"grant","acquired":true,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/12 of the Option vests in each monthly installment as measured from May 30, 2019, until the earlier of the Option's full vesting or the reporting person ceasing to provide continuous service to the issuer.  In addition, in the event of a Change in Control or a Corporate Transaction (each as defined in the plan pursuant to which the Option was granted), any unvested portion of the Option will fully vest and become exercisable as of immediately prior to the effective time of such Change in Control or Corporate Transaction, subject to the reporting person's continuous service on the effective date of such transaction."}],"balance_after":11000,"derivative":{"exercise_price":5.42,"expiration_date":"2029-05-29","underlying":"Common Stock","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0000899243-19-015383","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496671/000089924319015383/doc4.xml","form_type":"4"}},{"id":3573561,"issuer":{"id":11424,"kind":"organization","name":"Harpoon Therapeutics, Inc.","symbol":"HARP"},"owners":[{"id":93214,"kind":"person","name":"DRACHMAN JONATHAN G","position":1,"cik":"0001588467","reported_name":"DRACHMAN JONATHAN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2019-03-29T16:17:51.000Z","date":"2019-02-07","kind":"grant","acquired":true,"shares":4266,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable as to 25% of the shares subject to the option on the last day of each calendar quarter following the grant date of February 7, 2019 (on March 31, 2019, June 30, 2019, September 30, 2019, and December 31, 2019), subject to the continuous service of the Reporting Person on each vesting date."}],"balance_after":4266,"derivative":{"exercise_price":14,"expiration_date":"2029-02-06","underlying":"Common Stock","underlying_shares":4266},"source":{"system":"sec-edgar","filing":"0001209191-19-021731","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1588467/000120919119021731/doc4.xml","form_type":"4"}},{"id":3908386,"issuer":{"id":113073,"kind":"organization","name":"Calithera Biosciences, Inc.","symbol":"CALA"},"owners":[{"id":93214,"kind":"person","name":"DRACHMAN JONATHAN G","position":1,"cik":"0001588467","reported_name":"DRACHMAN JONATHAN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-04T16:06:07.000Z","date":"2018-05-31","kind":"grant","acquired":true,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/12 of the Option vests in each monthly installment as measured from May 31, 2018, until the earlier of the Option's full vesting or the reporting person ceasing to provide continuous service to the issuer.  In addition, in the event of a Change in Control or a Corporate Transaction (each as defined in the plan pursuant to which the Option was granted), any unvested portion of the Option will fully vest and become exercisable as of immediately prior to the effective time of such Change in Control or Corporate Transaction, subject to the reporting person's continuous service on the effective date of such transaction."}],"balance_after":11000,"derivative":{"exercise_price":5.15,"expiration_date":"2028-05-30","underlying":"Common Stock","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0000899243-18-014883","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496671/000089924318014883/doc4.xml","form_type":"4"}},{"id":3985441,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":93214,"kind":"person","name":"DRACHMAN JONATHAN G","position":1,"cik":"0001588467","reported_name":"DRACHMAN JONATHAN G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Non-qualified Stock Option (Right to buy)","published_at":"2018-03-22T21:36:51.000Z","date":"2018-03-20","kind":"grant","acquired":true,"shares":10526,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On May 9, 2016, the reporting person was granted an option to purchase 10,526 options of common stock.  The performance criteria for this grant were met as of March 20, 2018 and the option shall vest in four (4) equal tranches on the first, second, third and fourth anniversaries of March 20, 2018 subject to continuous service with the Company as of each vesting date."}],"balance_after":10526,"derivative":{"exercise_price":34.2,"expiration_date":"2026-05-09","underlying":"Common Stock","underlying_shares":10526},"source":{"system":"sec-edgar","filing":"0000899243-18-008417","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000089924318008417/doc4.xml","form_type":"4"}},{"id":3985435,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":93214,"kind":"person","name":"DRACHMAN JONATHAN G","position":1,"cik":"0001588467","reported_name":"DRACHMAN JONATHAN G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO & EVP, R & D"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-03-22T19:04:20.000Z","date":"2018-03-20","kind":"exercise","acquired":false,"shares":13740,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Shares vested at a rate of 25% on 8/27/11 and monthly thereafter until all the shares were fully vested on 8/27/14."}],"balance_after":45000,"derivative":{"exercise_price":12,"expiration_date":"2020-08-27","underlying":"Common Stock","underlying_shares":13740},"source":{"system":"sec-edgar","filing":"0001203311-18-000020","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331118000020/edgardoc.xml","form_type":"4"}},{"id":3985434,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":93214,"kind":"person","name":"DRACHMAN JONATHAN G","position":1,"cik":"0001588467","reported_name":"DRACHMAN JONATHAN G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO & EVP, R & D"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-03-22T19:04:20.000Z","date":"2018-03-20","kind":"exercise","acquired":false,"shares":7000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Shares vested at a rate of 25% on 5/7/11 and monthly thereafter until all the shares were fully vested on 5/7/14"}],"balance_after":0,"derivative":{"exercise_price":10.61,"expiration_date":"2020-05-07","underlying":"Common Stock","underlying_shares":7000},"source":{"system":"sec-edgar","filing":"0001203311-18-000020","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331118000020/edgardoc.xml","form_type":"4"}},{"id":3985433,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":93214,"kind":"person","name":"DRACHMAN JONATHAN G","position":1,"cik":"0001588467","reported_name":"DRACHMAN JONATHAN G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO & EVP, R & D"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2018-03-22T19:04:20.000Z","date":"2018-03-20","kind":"exercise","acquired":false,"shares":3831,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares vested at a rate of 25% on 8/20/13 and monthly thereafter until all the shares were fully vested on 8/20/2016."}],"balance_after":0,"derivative":{"exercise_price":26.1,"expiration_date":"2022-08-20","underlying":"Common Stock","underlying_shares":3831},"source":{"system":"sec-edgar","filing":"0001203311-18-000020","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331118000020/edgardoc.xml","form_type":"4"}},{"id":3985432,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":93214,"kind":"person","name":"DRACHMAN JONATHAN G","position":1,"cik":"0001588467","reported_name":"DRACHMAN JONATHAN G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO & EVP, R & D"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2018-03-22T19:04:20.000Z","date":"2018-03-20","kind":"exercise","acquired":false,"shares":6468,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares vested at a rate of 25% on 8/24/12 and monthly thereafter until all the shares were fully vested on 8/27/15."}],"balance_after":0,"derivative":{"exercise_price":15.46,"expiration_date":"2021-08-24","underlying":"Common Stock","underlying_shares":6468},"source":{"system":"sec-edgar","filing":"0001203311-18-000020","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331118000020/edgardoc.xml","form_type":"4"}},{"id":3985431,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":93214,"kind":"person","name":"DRACHMAN JONATHAN G","position":1,"cik":"0001588467","reported_name":"DRACHMAN JONATHAN G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO & EVP, R & D"}}],"security":"Common Stock","published_at":"2018-03-22T19:04:20.000Z","date":"2018-03-20","kind":"exercise","acquired":true,"shares":7000,"price":10.61,"value":74270.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting."}],"balance_after":201973,"source":{"system":"sec-edgar","filing":"0001203311-18-000020","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331118000020/edgardoc.xml","form_type":"4"}},{"id":3985430,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":93214,"kind":"person","name":"DRACHMAN JONATHAN G","position":1,"cik":"0001588467","reported_name":"DRACHMAN JONATHAN G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO & EVP, R & D"}}],"security":"Common Stock","published_at":"2018-03-22T19:04:20.000Z","date":"2018-03-20","kind":"exercise","acquired":true,"shares":13740,"price":12,"value":164880.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting."}],"balance_after":194973,"source":{"system":"sec-edgar","filing":"0001203311-18-000020","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331118000020/edgardoc.xml","form_type":"4"}},{"id":3985429,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":93214,"kind":"person","name":"DRACHMAN JONATHAN G","position":1,"cik":"0001588467","reported_name":"DRACHMAN JONATHAN G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO & EVP, R & D"}}],"security":"Common Stock","published_at":"2018-03-22T19:04:20.000Z","date":"2018-03-20","kind":"exercise","acquired":true,"shares":6468,"price":15.46,"value":99995.28,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting."}],"balance_after":181233,"source":{"system":"sec-edgar","filing":"0001203311-18-000020","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331118000020/edgardoc.xml","form_type":"4"}},{"id":3985428,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":93214,"kind":"person","name":"DRACHMAN JONATHAN G","position":1,"cik":"0001588467","reported_name":"DRACHMAN JONATHAN G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO & EVP, R & D"}}],"security":"Common Stock","published_at":"2018-03-22T19:04:20.000Z","date":"2018-03-20","kind":"exercise","acquired":true,"shares":3831,"price":26.1,"value":99989.1,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting."}],"balance_after":174765,"source":{"system":"sec-edgar","filing":"0001203311-18-000020","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331118000020/edgardoc.xml","form_type":"4"}},{"id":4008746,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":93214,"kind":"person","name":"DRACHMAN JONATHAN G","position":1,"cik":"0001588467","reported_name":"DRACHMAN JONATHAN G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO & EVP, R & D"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-03-07T20:25:57.000Z","date":"2018-03-05","kind":"exercise","acquired":false,"shares":3257,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Shares vested at a rate of 25% on 3/23/09 and monthly thereafter until all the shares were fully vested on 3/23/12."}],"balance_after":0,"derivative":{"exercise_price":8.96,"expiration_date":"2018-03-23","underlying":"Common Stock","underlying_shares":3257},"source":{"system":"sec-edgar","filing":"0001203311-18-000012","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331118000012/edgardoc.xml","form_type":"4"}},{"id":4008745,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":93214,"kind":"person","name":"DRACHMAN JONATHAN G","position":1,"cik":"0001588467","reported_name":"DRACHMAN JONATHAN G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO & EVP, R & D"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-03-07T20:25:57.000Z","date":"2018-03-05","kind":"exercise","acquired":false,"shares":7200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Shares vested at a rate of 25% on 3/23/09 and monthly thereafter until all the shares were fully vested on 3/23/12."}],"balance_after":3257,"derivative":{"exercise_price":8.96,"expiration_date":"2018-03-23","underlying":"Common Stock","underlying_shares":7200},"source":{"system":"sec-edgar","filing":"0001203311-18-000012","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331118000012/edgardoc.xml","form_type":"4"}},{"id":4008744,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":93214,"kind":"person","name":"DRACHMAN JONATHAN G","position":1,"cik":"0001588467","reported_name":"DRACHMAN JONATHAN G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO & EVP, R & D"}}],"security":"Common Stock","published_at":"2018-03-07T20:25:57.000Z","date":"2018-03-05","kind":"sale","acquired":false,"shares":3257,"price":53.12,"value":173011.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $52.94 to $53.45. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting and 381 shares acquired under the Amended and Restated 2000 Employee Stock Purchase Plan on January 31, 2018."}],"balance_after":170934,"source":{"system":"sec-edgar","filing":"0001203311-18-000012","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331118000012/edgardoc.xml","form_type":"4"}},{"id":4008743,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":93214,"kind":"person","name":"DRACHMAN JONATHAN G","position":1,"cik":"0001588467","reported_name":"DRACHMAN JONATHAN G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO & EVP, R & D"}}],"security":"Common Stock","published_at":"2018-03-07T20:25:57.000Z","date":"2018-03-05","kind":"exercise","acquired":true,"shares":3257,"price":8.96,"value":29182.72,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting and 381 shares acquired under the Amended and Restated 2000 Employee Stock Purchase Plan on January 31, 2018."}],"balance_after":174191,"source":{"system":"sec-edgar","filing":"0001203311-18-000012","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331118000012/edgardoc.xml","form_type":"4"}},{"id":4008742,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":93214,"kind":"person","name":"DRACHMAN JONATHAN G","position":1,"cik":"0001588467","reported_name":"DRACHMAN JONATHAN G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO & EVP, R & D"}}],"security":"Common Stock","published_at":"2018-03-07T20:25:57.000Z","date":"2018-03-05","kind":"sale","acquired":false,"shares":7200,"price":52.7,"value":379440.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $51.93 to $52.92. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting and 381 shares acquired under the Amended and Restated 2000 Employee Stock Purchase Plan on January 31, 2018."}],"balance_after":170934,"source":{"system":"sec-edgar","filing":"0001203311-18-000012","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331118000012/edgardoc.xml","form_type":"4"}},{"id":4008741,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":93214,"kind":"person","name":"DRACHMAN JONATHAN G","position":1,"cik":"0001588467","reported_name":"DRACHMAN JONATHAN G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO & EVP, R & D"}}],"security":"Common Stock","published_at":"2018-03-07T20:25:57.000Z","date":"2018-03-05","kind":"exercise","acquired":true,"shares":7200,"price":8.96,"value":64512.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting and 381 shares acquired under the Amended and Restated 2000 Employee Stock Purchase Plan on January 31, 2018."}],"balance_after":178134,"source":{"system":"sec-edgar","filing":"0001203311-18-000012","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331118000012/edgardoc.xml","form_type":"4"}},{"id":4099577,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":93214,"kind":"person","name":"DRACHMAN JONATHAN G","position":1,"cik":"0001588467","reported_name":"DRACHMAN JONATHAN G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO & EVP, R & D"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-01-16T20:04:44.000Z","date":"2018-01-11","kind":"exercise","acquired":false,"shares":13156,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares vested at a rate of 25% on 5/7/11 and monthly thereafter until all the shares were fully vested on 5/7/14."}],"balance_after":7000,"derivative":{"exercise_price":10.61,"expiration_date":"2020-05-07","underlying":"Common Stock","underlying_shares":13156},"source":{"system":"sec-edgar","filing":"0001203311-18-000002","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331118000002/edgardoc.xml","form_type":"4"}},{"id":4099576,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":93214,"kind":"person","name":"DRACHMAN JONATHAN G","position":1,"cik":"0001588467","reported_name":"DRACHMAN JONATHAN G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO & EVP, R & D"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2018-01-16T20:04:44.000Z","date":"2018-01-11","kind":"exercise","acquired":false,"shares":6260,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares vested at a rate of 25% on 8/27/11 and monthly thereafter until all the shares were fully vested on 8/27/14."}],"balance_after":0,"derivative":{"exercise_price":12,"expiration_date":"2020-08-27","underlying":"Common Stock","underlying_shares":6260},"source":{"system":"sec-edgar","filing":"0001203311-18-000002","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331118000002/edgardoc.xml","form_type":"4"}},{"id":4099575,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":93214,"kind":"person","name":"DRACHMAN JONATHAN G","position":1,"cik":"0001588467","reported_name":"DRACHMAN JONATHAN G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO & EVP, R & D"}}],"security":"Common Stock","published_at":"2018-01-16T20:04:44.000Z","date":"2018-01-11","kind":"exercise","acquired":true,"shares":13156,"price":10.61,"value":139585.16,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting."}],"balance_after":170934,"source":{"system":"sec-edgar","filing":"0001203311-18-000002","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331118000002/edgardoc.xml","form_type":"4"}},{"id":4099574,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":93214,"kind":"person","name":"DRACHMAN JONATHAN G","position":1,"cik":"0001588467","reported_name":"DRACHMAN JONATHAN G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO & EVP, R & D"}}],"security":"Common Stock","published_at":"2018-01-16T20:04:44.000Z","date":"2018-01-11","kind":"exercise","acquired":true,"shares":6260,"price":12,"value":75120.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting."}],"balance_after":157778,"source":{"system":"sec-edgar","filing":"0001203311-18-000002","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331118000002/edgardoc.xml","form_type":"4"}},{"id":4189324,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":93214,"kind":"person","name":"DRACHMAN JONATHAN G","position":1,"cik":"0001588467","reported_name":"DRACHMAN JONATHAN G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO & EVP, R & D"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2017-10-10T18:42:14.000Z","date":"2017-10-05","kind":"exercise","acquired":false,"shares":8223,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Shares vested at a rate of 25% on 8/25/10 and monthly thereafter until all the shares were fully vested on 8/25/13."}],"balance_after":0,"derivative":{"exercise_price":12.16,"expiration_date":"2019-08-25","underlying":"Common Stock","underlying_shares":8223},"source":{"system":"sec-edgar","filing":"0001203311-17-000084","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331117000084/edgardoc.xml","form_type":"4"}},{"id":4189323,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":93214,"kind":"person","name":"DRACHMAN JONATHAN G","position":1,"cik":"0001588467","reported_name":"DRACHMAN JONATHAN G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO & EVP, R & D"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2017-10-10T18:42:14.000Z","date":"2017-10-05","kind":"exercise","acquired":false,"shares":7249,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares vested at a rate of 25% on 8/27/09 and monthly thereafter until all the shares were fully vested on 8/27/12."}],"balance_after":0,"derivative":{"exercise_price":11.09,"expiration_date":"2018-08-27","underlying":"Common Stock","underlying_shares":7249},"source":{"system":"sec-edgar","filing":"0001203311-17-000084","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331117000084/edgardoc.xml","form_type":"4"}},{"id":4189322,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":93214,"kind":"person","name":"DRACHMAN JONATHAN G","position":1,"cik":"0001588467","reported_name":"DRACHMAN JONATHAN G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO & EVP, R & D"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2017-10-10T18:42:14.000Z","date":"2017-10-05","kind":"exercise","acquired":false,"shares":2344,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares vested at a rate of 25% on 5/7/11 and monthly thereafter until all the shares were fully vested on 5/7/14."}],"balance_after":0,"derivative":{"exercise_price":10.61,"expiration_date":"2020-05-07","underlying":"Common Stock","underlying_shares":2344},"source":{"system":"sec-edgar","filing":"0001203311-17-000084","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331117000084/edgardoc.xml","form_type":"4"}},{"id":4189321,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":93214,"kind":"person","name":"DRACHMAN JONATHAN G","position":1,"cik":"0001588467","reported_name":"DRACHMAN JONATHAN G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO & EVP, R & D"}}],"security":"Common Stock","published_at":"2017-10-10T18:42:14.000Z","date":"2017-10-05","kind":"exercise","acquired":true,"shares":8223,"price":12.16,"value":99991.68,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting."}],"balance_after":151518,"source":{"system":"sec-edgar","filing":"0001203311-17-000084","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331117000084/edgardoc.xml","form_type":"4"}},{"id":4189320,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":93214,"kind":"person","name":"DRACHMAN JONATHAN G","position":1,"cik":"0001588467","reported_name":"DRACHMAN JONATHAN G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO & EVP, R & D"}}],"security":"Common Stock","published_at":"2017-10-10T18:42:14.000Z","date":"2017-10-05","kind":"exercise","acquired":true,"shares":2344,"price":10.61,"value":24869.84,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting."}],"balance_after":143295,"source":{"system":"sec-edgar","filing":"0001203311-17-000084","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331117000084/edgardoc.xml","form_type":"4"}},{"id":4189319,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":93214,"kind":"person","name":"DRACHMAN JONATHAN G","position":1,"cik":"0001588467","reported_name":"DRACHMAN JONATHAN G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO & EVP, R & D"}}],"security":"Common Stock","published_at":"2017-10-10T18:42:14.000Z","date":"2017-10-05","kind":"exercise","acquired":true,"shares":7249,"price":11.09,"value":80391.41,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting."}],"balance_after":140951,"source":{"system":"sec-edgar","filing":"0001203311-17-000084","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331117000084/edgardoc.xml","form_type":"4"}},{"id":4221845,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":93214,"kind":"person","name":"DRACHMAN JONATHAN G","position":1,"cik":"0001588467","reported_name":"DRACHMAN JONATHAN G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO & EVP, R & D"}}],"security":"Common Stock","published_at":"2017-08-30T19:23:04.000Z","date":"2017-08-28","kind":"sale","acquired":false,"shares":8502,"price":47.8945,"value":407199.039,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold pursuant to a 10b5-1 arrangement to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting."}],"balance_after":133702,"source":{"system":"sec-edgar","filing":"0001203311-17-000062","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331117000062/edgardoc.xml","form_type":"4"}},{"id":4224655,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":93214,"kind":"person","name":"DRACHMAN JONATHAN G","position":1,"cik":"0001588467","reported_name":"DRACHMAN JONATHAN G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO & EVP, R & D"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2017-08-25T19:52:10.000Z","date":"2017-08-24","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Shares vested at a rate of 25% on 8/28/2007 and monthly thereafter until all the shares were fully vested on 8/28/2011."}],"balance_after":0,"derivative":{"exercise_price":10.29,"expiration_date":"2017-08-28","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001203311-17-000056","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331117000056/edgardoc.xml","form_type":"4"}},{"id":4224654,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":93214,"kind":"person","name":"DRACHMAN JONATHAN G","position":1,"cik":"0001588467","reported_name":"DRACHMAN JONATHAN G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO & EVP, R & D"}}],"security":"Common Stock","published_at":"2017-08-25T19:52:10.000Z","date":"2017-08-24","kind":"sale","acquired":false,"shares":10000,"price":47.5414,"value":475414.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $47.29 to $47.88. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting."}],"balance_after":142204,"source":{"system":"sec-edgar","filing":"0001203311-17-000056","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331117000056/edgardoc.xml","form_type":"4"}},{"id":4224653,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":93214,"kind":"person","name":"DRACHMAN JONATHAN G","position":1,"cik":"0001588467","reported_name":"DRACHMAN JONATHAN G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO & EVP, R & D"}}],"security":"Common Stock","published_at":"2017-08-25T19:52:10.000Z","date":"2017-08-24","kind":"exercise","acquired":true,"shares":10000,"price":10.29,"value":102900.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting."}],"balance_after":152204,"source":{"system":"sec-edgar","filing":"0001203311-17-000056","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331117000056/edgardoc.xml","form_type":"4"}},{"id":4229801,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":93214,"kind":"person","name":"DRACHMAN JONATHAN G","position":1,"cik":"0001588467","reported_name":"DRACHMAN JONATHAN G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO & EVP, R & D"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2017-08-18T20:23:49.000Z","date":"2017-08-17","kind":"grant","acquired":true,"shares":65344,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Shares shall vest at a rate of 25% one year from grant date and monthly thereafter until all shares are fully vested four years form grant date."}],"balance_after":65344,"derivative":{"exercise_price":46.37,"expiration_date":"2027-08-17","underlying":"Common Stock","underlying_shares":65344},"source":{"system":"sec-edgar","filing":"0001203311-17-000046","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331117000046/edgardoc.xml","form_type":"4"}},{"id":4229800,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":93214,"kind":"person","name":"DRACHMAN JONATHAN G","position":1,"cik":"0001588467","reported_name":"DRACHMAN JONATHAN G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO & EVP, R & D"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2017-08-18T20:23:49.000Z","date":"2017-08-17","kind":"grant","acquired":true,"shares":2156,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Shares shall vest at a rate of 25% one year from grant date and monthly thereafter until all shares are fully vested four years form grant date."}],"balance_after":2156,"derivative":{"exercise_price":46.37,"expiration_date":"2027-08-17","underlying":"Common Stock","underlying_shares":2156},"source":{"system":"sec-edgar","filing":"0001203311-17-000046","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331117000046/edgardoc.xml","form_type":"4"}},{"id":4229799,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":93214,"kind":"person","name":"DRACHMAN JONATHAN G","position":1,"cik":"0001588467","reported_name":"DRACHMAN JONATHAN G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO & EVP, R & D"}}],"security":"Common Stock","published_at":"2017-08-18T20:23:49.000Z","date":"2017-08-17","kind":"grant","acquired":true,"shares":27000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These shares represent restricted stock units and will be settled in common stock upon vesting."},{"field":"date","element":"transactionDate","label":"F2","text":"Restricted stock units shall vest in full three (3) years from grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting and 116 shares acquired under the Amended and Restated 2000 Employee Stock Purchase Plan on July 31, 2017."}],"balance_after":142204,"source":{"system":"sec-edgar","filing":"0001203311-17-000046","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331117000046/edgardoc.xml","form_type":"4"}},{"id":4248692,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":93214,"kind":"person","name":"DRACHMAN JONATHAN G","position":1,"cik":"0001588467","reported_name":"DRACHMAN JONATHAN G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO & EVP, R & D"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2017-07-31T19:15:58.000Z","date":"2017-07-27","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Shares vested at a rate of 25% on 8/28/2008 and monthly thereafter until all the shares were fully vested on 8/28/2011."}],"balance_after":10000,"derivative":{"exercise_price":10.29,"expiration_date":"2017-08-28","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001203311-17-000036","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331117000036/edgardoc.xml","form_type":"4"}},{"id":4248691,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":93214,"kind":"person","name":"DRACHMAN JONATHAN G","position":1,"cik":"0001588467","reported_name":"DRACHMAN JONATHAN G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO & EVP, R & D"}}],"security":"Common Stock","published_at":"2017-07-31T19:15:58.000Z","date":"2017-07-27","kind":"sale","acquired":false,"shares":10000,"price":54.5361,"value":545361.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $54.10 to $54.97. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting."}],"balance_after":115204,"source":{"system":"sec-edgar","filing":"0001203311-17-000036","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331117000036/edgardoc.xml","form_type":"4"}},{"id":4248690,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":93214,"kind":"person","name":"DRACHMAN JONATHAN G","position":1,"cik":"0001588467","reported_name":"DRACHMAN JONATHAN G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO & EVP, R & D"}}],"security":"Common Stock","published_at":"2017-07-31T19:15:58.000Z","date":"2017-07-27","kind":"exercise","acquired":true,"shares":10000,"price":10.29,"value":102900.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting."}],"balance_after":125204,"source":{"system":"sec-edgar","filing":"0001203311-17-000036","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331117000036/edgardoc.xml","form_type":"4"}},{"id":4272766,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":93214,"kind":"person","name":"DRACHMAN JONATHAN G","position":1,"cik":"0001588467","reported_name":"DRACHMAN JONATHAN G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO & EVP, R & D"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2017-06-26T18:25:48.000Z","date":"2017-06-22","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Shares vested at a rate of 25% on 8/28/08 and monthly thereafter until all the shares were fully vested on 8/28/11."}],"balance_after":20000,"derivative":{"exercise_price":10.29,"expiration_date":"2017-08-28","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001203311-17-000032","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331117000032/edgardoc.xml","form_type":"4"}},{"id":4272765,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":93214,"kind":"person","name":"DRACHMAN JONATHAN G","position":1,"cik":"0001588467","reported_name":"DRACHMAN JONATHAN G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO & EVP, R & D"}}],"security":"Common Stock","published_at":"2017-06-26T18:25:48.000Z","date":"2017-06-22","kind":"sale","acquired":false,"shares":100,"price":64.58,"value":6458.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting."}],"balance_after":115204,"source":{"system":"sec-edgar","filing":"0001203311-17-000032","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331117000032/edgardoc.xml","form_type":"4"}},{"id":4272764,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":93214,"kind":"person","name":"DRACHMAN JONATHAN G","position":1,"cik":"0001588467","reported_name":"DRACHMAN JONATHAN G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO & EVP, R & D"}}],"security":"Common Stock","published_at":"2017-06-26T18:25:48.000Z","date":"2017-06-22","kind":"sale","acquired":false,"shares":9900,"price":64,"value":633600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $63.47 to $64.29. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting."}],"balance_after":115304,"source":{"system":"sec-edgar","filing":"0001203311-17-000032","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331117000032/edgardoc.xml","form_type":"4"}},{"id":4272763,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":93214,"kind":"person","name":"DRACHMAN JONATHAN G","position":1,"cik":"0001588467","reported_name":"DRACHMAN JONATHAN G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO & EVP, R & D"}}],"security":"Common Stock","published_at":"2017-06-26T18:25:48.000Z","date":"2017-06-22","kind":"exercise","acquired":true,"shares":10000,"price":10.29,"value":102900.0,"ownership":{"direct":true},"balance_after":125204,"source":{"system":"sec-edgar","filing":"0001203311-17-000032","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331117000032/edgardoc.xml","form_type":"4"}},{"id":4283829,"issuer":{"id":113073,"kind":"organization","name":"Calithera Biosciences, Inc.","symbol":"CALA"},"owners":[{"id":93214,"kind":"person","name":"DRACHMAN JONATHAN G","position":1,"cik":"0001588467","reported_name":"DRACHMAN JONATHAN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-06-13T16:36:55.000Z","date":"2017-06-09","kind":"grant","acquired":true,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/12 of the Option vests in each monthly installment as measured from June 09, 2017, until the earlier of the Option's full vesting or the reporting person ceasing to provide continuous service to the issuer.  In addition, in the event of a Change in Control or a Corporate Transaction (each as defined in the plan pursuant to which the Option was granted), any unvested portion of the Option will fully vest and become exercisable as of immediately prior to the effective time of such Change in Control or Corporate Transaction, subject to the reporting person's continuous service on the effective date of such transaction."}],"balance_after":11000,"derivative":{"exercise_price":14.2,"expiration_date":"2027-06-08","underlying":"Common Stock","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0000899243-17-016235","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496671/000089924317016235/doc4.xml","form_type":"4"}},{"id":4480785,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":93214,"kind":"person","name":"DRACHMAN JONATHAN G","position":1,"cik":"0001588467","reported_name":"DRACHMAN JONATHAN G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO & EVP, R & D"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2017-01-26T19:41:20.000Z","date":"2017-01-25","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares vested at a rate of 25% on 8/28/08 and monthly thereafter until all the shares were fully vested on 8/28/11."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting."}],"balance_after":0,"derivative":{"exercise_price":10.29,"expiration_date":"2017-08-28","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001203311-17-000004","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331117000004/edgardoc.xml","form_type":"4"}},{"id":4480784,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":93214,"kind":"person","name":"DRACHMAN JONATHAN G","position":1,"cik":"0001588467","reported_name":"DRACHMAN JONATHAN G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO & EVP, R & D"}}],"security":"Common Stock","published_at":"2017-01-26T19:41:20.000Z","date":"2017-01-25","kind":"exercise","acquired":true,"shares":5000,"price":10.29,"value":51450.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting."}],"balance_after":114837,"source":{"system":"sec-edgar","filing":"0001203311-17-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331117000004/edgardoc.xml","form_type":"4"}},{"id":4558540,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":93214,"kind":"person","name":"DRACHMAN JONATHAN G","position":1,"cik":"0001588467","reported_name":"DRACHMAN JONATHAN G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO & EVP, R & D"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2016-11-14T17:55:14.000Z","date":"2016-11-09","kind":"exercise","acquired":false,"shares":7751,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares vested at a rate of 25% on 8/27/09 and monthly thereafter until all the shares were fully vested on 8/27/12."}],"balance_after":40000,"derivative":{"exercise_price":11.09,"expiration_date":"2018-08-27","underlying":"Common Stock","underlying_shares":7751},"source":{"system":"sec-edgar","filing":"0001203311-16-000173","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331116000173/edgardoc.xml","form_type":"4"}},{"id":4558539,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":93214,"kind":"person","name":"DRACHMAN JONATHAN G","position":1,"cik":"0001588467","reported_name":"DRACHMAN JONATHAN G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO & EVP, R & D"}}],"security":"Common Stock","published_at":"2016-11-14T17:55:14.000Z","date":"2016-11-09","kind":"sale","acquired":false,"shares":7751,"price":66.75,"value":517379.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting."}],"balance_after":109837,"source":{"system":"sec-edgar","filing":"0001203311-16-000173","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331116000173/edgardoc.xml","form_type":"4"}},{"id":4558538,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":93214,"kind":"person","name":"DRACHMAN JONATHAN G","position":1,"cik":"0001588467","reported_name":"DRACHMAN JONATHAN G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO & EVP, R & D"}}],"security":"Common Stock","published_at":"2016-11-14T17:55:14.000Z","date":"2016-11-09","kind":"exercise","acquired":true,"shares":7751,"price":11.09,"value":85958.59,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting."}],"balance_after":117588,"source":{"system":"sec-edgar","filing":"0001203311-16-000173","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331116000173/edgardoc.xml","form_type":"4"}},{"id":4568310,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":93214,"kind":"person","name":"DRACHMAN JONATHAN G","position":1,"cik":"0001588467","reported_name":"DRACHMAN JONATHAN G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO & EVP, R & D"}}],"security":"Common Stock","published_at":"2016-11-03T20:04:11.000Z","date":"2016-11-01","kind":"sale","acquired":false,"shares":3418,"price":51.74,"value":176847.32,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares sold pursuant to a 10b5-1 arrangement to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting."}],"balance_after":109837,"source":{"system":"sec-edgar","filing":"0001203311-16-000165","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331116000165/edgardoc.xml","form_type":"4"}},{"id":4596458,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":93214,"kind":"person","name":"DRACHMAN JONATHAN G","position":1,"cik":"0001588467","reported_name":"DRACHMAN JONATHAN G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO & EVP, R & D"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2016-09-23T19:12:35.000Z","date":"2016-09-22","kind":"exercise","acquired":false,"shares":2249,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares vested at a rate of 25% on 8/28/08 and monthly thereafter until all the shares were fully vested on 8/28/11."}],"balance_after":30000,"derivative":{"exercise_price":10.29,"expiration_date":"2017-08-28","underlying":"Common Stock","underlying_shares":2249},"source":{"system":"sec-edgar","filing":"0001203311-16-000161","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331116000161/edgardoc.xml","form_type":"4"}},{"id":4596457,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":93214,"kind":"person","name":"DRACHMAN JONATHAN G","position":1,"cik":"0001588467","reported_name":"DRACHMAN JONATHAN G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO & EVP, R & D"}}],"security":"Common Stock","published_at":"2016-09-23T19:12:35.000Z","date":"2016-09-22","kind":"sale","acquired":false,"shares":2249,"price":56.75,"value":127630.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting."}],"balance_after":113255,"source":{"system":"sec-edgar","filing":"0001203311-16-000161","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331116000161/edgardoc.xml","form_type":"4"}},{"id":4596456,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":93214,"kind":"person","name":"DRACHMAN JONATHAN G","position":1,"cik":"0001588467","reported_name":"DRACHMAN JONATHAN G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO & EVP, R & D"}}],"security":"Common Stock","published_at":"2016-09-23T19:12:35.000Z","date":"2016-09-22","kind":"exercise","acquired":true,"shares":2249,"price":10.29,"value":23142.21,"ownership":{"direct":true},"balance_after":115504,"source":{"system":"sec-edgar","filing":"0001203311-16-000161","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331116000161/edgardoc.xml","form_type":"4"}}]}